1 |
Kanzaki R, Higashiyama M, Fujiwara A, et al. Outcome of surgical resection of pulmonary metastasis from urinary tract transitional cell carcinoma. Interact Cardiovasc Thorac Surg 2010;11:60-4.
DOI
|
2 |
Sternberg CN, Yagoda A, Scher HI, et al. Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. J Urol 1985;133:403-7.
DOI
|
3 |
Rusch VW. Pulmonary metastasectomy: current indications. Chest 1995;107(6 Suppl):322S-31.
DOI
|
4 |
Montie JE, Clark PE, Eisenberger MA, et al. Bladder cancer. J Natl Compr Canc Netw 2009;7:8-39.
DOI
|
5 |
Park JS, Kim HK, Choi YS, et al. Outcomes after repeated resection for recurrent pulmonary metastases from colorectal cancer. Ann Oncol 2010;21:1285-9.
DOI
ScienceOn
|
6 |
Siefker-Radtke AO, Walsh GL, Pisters LL, et al. Is there a role for surgery in the management of metastatic urothelial cancer? The M. D. Anderson experience. J Urol 2004;171: 145-8.
DOI
ScienceOn
|
7 |
Abe T, Shinohara N, Harabayashi T, et al. Impact of multimodal treatment on survival in patients with metastatic urothelial cancer. Eur Urol 2007;52:1106-13.
DOI
ScienceOn
|
8 |
Matsuguma H, Yoshino I, Ito H, et al. Is there a role for pulmonary metastasectomy with a curative intent in patients with metastatic urinary transitional cell carcinoma? Ann Thorac Surg 2011;92:449-53.
DOI
ScienceOn
|